Open AccessYttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review
Author(s) -
Michael Feretis,
Andriy Solodkyy
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i2.228
Subject(s) - medicine , systematic review , breast cancer , randomized controlled trial , colorectal cancer , cancer , oncology , medline , radiology , political science , law
Liver metastases secondary to breast cancer are associated with unfavourable prognosis. Radioembolization with ytrrium-90 is an emerging option for management of liver metastases of breast cancer when other systemic therapies have failed to achieve disease control. However, unlike the case of other liver tumours (colorectal/melanoma metastases/cholangiocarcinoma), its role in the management of breast liver metastases is yet to be elucidated.